US Patent 10246462 Chemokine receptor modulators and uses thereof
Patent 10246462 was granted and assigned to Flx Bio, Inc. on April, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 8, 2017
Date of Patent
April 2, 2019
Patent Applicant
Patent Application Number
15700040
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10246462 Chemokine receptor modulators and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.